Background. Hepatitis C virus (HCV) is a major cause of liver disease worldwide, with steatosis, or "fatty liver," being a frequent histologic finding. In previous work, we identified sequence polymorphisms within domain 3 (d3) of genotype 3 HCV core protein that correlated with steatosis and in vitro lipid accumulation. In this study, we investigated the sufficiency of d3 to promote lipid accumulation, the role of HCV genotype in d3 lipid accumulation, and the subcellular distribution of d3.
Hepatitis C virus (HCV) is a major cause of liver disease worldwide and the leading indication for adult liver transplantation in the United States [1] . Hepatic steatosis is present in ∼50% of HCV-infected patients; however, the rates differ according to HCV genotype [2] [3] [4] . Patients infected with HCV genotype 3 have steatosis more often and of higher grade than patients infected with genotype 1 [5, 6] . Up to 80% of genotype 3-infected patients have steatosis, and several studies have indicated that steatosis in these patients correlates closely with measures of viral activity [7] [8] [9] [10] [11] . This is in contrast to genotype 1-infected patients, in whom the major risk factors for steatosis are obesity, diabetes, and alcohol use [12] [13] [14] [15] . Steatosis has proven to be a major risk factor for fibrosis progression and carcinogenesis [8, [16] [17] [18] .
Studies of the pathogenesis of HCV-associated steatosis have frequently implicated the core protein. HCV core forms the nucleocapsid of the virus and has been associated with altering a diverse range of intracellular pathways [19] [20] [21] . The most frequent pathway implicated is very low-density lipoprotein (VLDL) synthesis and the microsomal triglyceride transfer protein [22, 23] . Lipid accumulation now appears to be an integral part of the viral life cycle [24, 25] . Recent studies have shown that HCV uses the VLDL synthesis pathway for virus release and that core protein binding to lipid droplets is required for efficient virus assembly and production [24] [25] [26] [27] . These findings are consistent with data demonstrating that in vitro expression of core protein from a variety of genotypes leads to lipid accumulation [12, 28, 29] .
In previous work, we examined viral factors asso- TCC CTT GCT TTG TTC TCT TGC TTA GTT CAT CCA GCA GCA AGT TGA TGA T  d3S EcoRI-XbaI anti-sense  CTA GAT CAT CAA CTT GCT GCT GGA TGA ACT AAG CAA GAG AAC AAA GCA AGG G   d3NS EcoRI-XbaI sense  AAT TCC CTT GCT TTG TTC TCT TGC TTA ATT CAT CCA GCA GCA AGT TGA TGA T  d3NS EcoRI-XbaI anti-sense CTA GAT CAT CAA CTT GCT GCT GGA TGA ATT AAG CAA GAG AAC AAA GCA AGG G  d3G1 EcoRI-XbaI sense  AAT TCC CTG GCC CTG CTC TCT TGC CTG ACT GTG CCC GCT TCA GCC TGA TGA T  d3G1 EcoRI-XbaI anti-sense CTA GAT CAT CAG GCT GAA GCG GGC ACA GTC AGG CAA GAG AGC AGG GCC AGG G d2-d3 EcoRI sense GTG CGA ATT CGA ACT TGG GTA AAG TCA TCG Figure 1 . Validation that domain 3 (d3) of hepatitis C virus (HCV) expresses stably transfected cells. A, Schematic of green fluorescent protein (GFP) control and GFP-d3 fusions, with the exact sequence corresponding to each of the different d3 constructs tested: steatosis-associated d3 (d3S), genotype 1 d3 (d3G1), and non-steatosis-associated d3 (d3NS). B, Western blot analysis of lysates prepared from cell lines stably expressing GFP and GFP-d3 fusions by means of primary antibodies against both GFP and b-actin (loading control).
ciated with lipid accumulation in HCV genotype 3 infection and identified specific polymorphisms at amino acid residues 182 and 186 within domain 3 (d3) of the core protein that correlated with the presence or absence of steatosis in a small group of patients [28] . We recapitulated these differences in an in vitro system of hepatocyte lipid accumulation and thus demonstrated that core proteins that carry these polymorphisms induce more lipid accumulation. We report here the results of follow-up studies we performed to test the hypothesis that d3 alone is sufficient to cause intracellular lipid accumulation. We demonstrate that HCV core d3 green fluorescent protein (GFP) fusions promote more lipid droplets of greater size and increased triglyceride content. We show that d3 sequence differences within genotype 3 and between genotypes 3 and 1 determine the amount of lipid accumulation and that d3 does not exert its action by direct interaction with lipid droplets but appears to partially colocalize with the Golgi apparatus.
METHODS

HCV constructs.
The HCV core sequences that were used as templates for subsequent experiments included steatosis-associated d3 (d3S) (HCV1 DCRI, GenBank accession no. EU099414), non-steatosis-associated d3 (d3NS) (HCV11 DCRI, GenBank accession no. EU099415) [28] , and genotype 1 d3 (d3G1) (HCV-N, GenBank accession no. AF139594, provided by Dr Steve Weinman, University of Texas Medical Branch, Galveston) [30] .
Plasmid construction. The plasmid named "78" (provided by Dr Brian Doehle, Duke University Medical Center, Durham, NC) was used for generating GFP fusions. Plasmid 78 contained the backbone of pcDNA3 ligated with an NdeI-EcoRI fragment from pEGFP-C, which contained part of the cytomegalovirus promoter, the GFP open reading frame, and part of the multiple cloning site. We designed custom oligonucleotides (Table 1) to generate the constructs d3S, d3NS, d3G1, and domain 2 (d2) retained with d3 (d2-d3). We used EcoRI and XbaI, which we subsequently cloned into digested and purified vector. Ligated products were transformed into Escherichia coli, and colonies were selected after overnight growth on Luria-Bertani agar containing ampicillin. Recombinant plasmids were purified and sequenced to verify code and frame.
Generation of stable cell lines. Rat-derived 5H cells were transfected using JetPEI reagent (Polyplus) according to the manufacturer's recommended protocol. After 24 h, cells were transferred to a 150-mm dish and incubated with medium containing 2 mg/mL G418 for selection. Subsequent colonies were isolated and maintained in medium containing 1 mg/mL G418.
Fluorescent microscopy and oil red O (ORO) staining. The GFP-core construct cell lines were passaged into 4-well chamber slides and grown overnight. Cells were then fixed and stained with ORO as described elsewhere [28] . In brief, cells were washed twice in phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde for 30 min at 37ЊC, permeabilized with 0.1% Triton-X in PBS for 5 min, and washed and stained with 4 ,6-diamidino-2-phenylindol (DAPI) in methanol (1:1000 concentration) for 3 min at 25ЊC. Cells were washed with PBS 2 times and with propylene glycol 3 times for 5 min each. ORO stain in propylene glycol (Newcomer Supply) was applied to cells for 7 min, and then cells were washed in 85% propylene glycol for 3 min. Cells underwent distilled water rinse twice and were mounted using PBS in glycerol at a 1:1 concentration. Slides were examined using an Axiovert 200 microscope (Carl Zeiss) with epifluorescent illumination, and images were recorded using an AxioCam high-resolution camera (Carl Zeiss) and Axiovision software (version 4.4; Carl Zeiss), with the same settings used for all photographs.
ORO quantitation using MetaMorph software (Molecular Devices). For each stable cell line, 20 contiguous high-power (100ϫ magnification) fields were photographed for analysis. We used MetaMorph software to compare the amount of ORO content in each cell line as described elsewhere [28] . First we analyzed the entire field by applying a blue threshold to measure the percentage of the field with DAPI fluorescence, and then we analyzed the corresponding bright-field image by applying a red threshold to analyze the percentage of the field with ORO staining. We divided the percentage of the field with ORO stain by the percentage of the field with DAPI fluorescence to control for the number of cells in a given field. This was done for each stable cell line; then means and standard deviations were calculated, and the results were compared using a 2-tailed Student t test [31] .
Triglyceride assay. Cells were maintained in a 150-mm dish , and GFP fusions with steatosisassociated d3 (d3S), genotype 1 d3 (d3G1), and non-steatosis-associated d3 (d3NS). We used b-actin as a loading control.
until confluence and then collected on the same day on which the experiment was performed. The cells were washed twice with PBS, 400 mL of PBS was added, the cells were collected by means of a cell scraper, and 10 mL of cells were saved for measuring protein concentration. For each sample, 100 mg of total protein was used to detect the triglyceride level. To extract lipid, 1.5 mL of chloroform in methanol (1:2 concentration) was added, and the samples were incubated at room temperature for 2 min, which was followed by vortex for 30 s. Then 500 mL of chloroform was added, which was followed by vortex for 30 s, and then 500 mL of PBS was added, which was followed by another vortex for 30 s. Samples were then centrifuged at 1000 g for 10 min at room temperature, and the lower phase was carefully collected. The lower phase was allowed to air-dry overnight, and the next day a 50-mL mixture (t-butanol, Triton X-114, and methanol at a 9:4:2 concentration) was added to redissolve the dried lipids. The triglyceride level was measured at 540 nm using a Serum Triglyceride Determination kit (Sigma-Aldrich) according to the manufacturer's instructions.
Immunofluorescence. Antibodies to adipose differentiation-related protein (ADRP), calnexin, Golgi 58k protein, and catalase (Abcam) were used for immunofluorescence experiments. Staining was performed as described above; primary antibody staining was performed for 30 min at 37ЊC, which was followed by 2 PBS washes and then staining with a secondary goat anti-mouse antibody conjugated to Alexa Fluor 594 (Molecular Probes-Invitrogen) for 30 min at 37ЊC. After 2 PBS washes, the staining procedure proceeded as described above with DAPI stain.
Endoplasmic reticulum (ER) stress and Western blot analysis. Untransfected 5H cells were used as a negative control for ER stress, and untrasfected cells that were incubated with 10 mg/mL tunicamycin for 24 h were used as a positive control. All cell lysates were prepared using Passive Lysis buffer (Promega) and subjected to immunoblot analysis by use of the following primary antibodies: GFP; glucose-regulated protein (GRP) 78; C/EBP homologous protein (CHOP), also known as GRP-94 (Abcam); b-actin (GenScript); and the secondary antibodies goat anti-mouse horseradish peroxidase and donkey anti-goat horseradish peroxidase (GenScript).
Transient transfections. Huh7.5 cells (provided by Dr Shelton Bradrick, Duke University Medical Center, Durham, NC) were transfected using JetPEI reagent (Polyplus) in a 4-well chamber slide. After 24 h, cells were stained according to the immunofluorescence protocol described above.
RESULTS
Generation of stable cells expressing GFP fusions.
Because all commercially available HCV core antibodies recognize epitopes within domains 1 and 2, we made d3-GFP fusion constructs so that we could independently monitor for the presence and localization of our d3 constructs. It is important to indicate that there are very few amino acid changes between the constructs and they are at fixed positions ( Figure 1A) .
We generated stable cell lines using rat liver 5H cells, which have low baseline lipid levels and are therefore a good system for our prior and ongoing experiments. Huh7 and HepG2 cells contain too much lipid at baseline to allow for analysis of lipid accumulation. As demonstrated in Figure 1B , stably transfected cells that expressed any of the constructs (control GFP, d3S, d3G1, or d3NS) all had equivalent levels of protein expression. d3 is sufficient for lipid accumulation. We used fluorescence microscopy to examine the alterations in lipid metabolism after d3 fusion protein expression. Control GFP cells had small scattered lipid droplets; this result was consistent with Figure 5 . Evidence that domain 3 (d3) does not colocalize with lipid droplets. Stable cell lines expressing green fluorescent protein (GFP) and GFP fusions with steatosis-associated d3 (d3S) and domain 2 (d2) retained with d3 (d2-d3) were analyzed via immunofluorescence by use of the antibody to adipose differentiation-related protein (ADRP), a marker for lipid droplets.
our previous experiments in transiently transfected cells ( Figure  2A ) [28] . Cells expressing the d3S construct had GFP fluorescence throughout the cytoplasm and large lipid droplets. These droplets usually had a perinuclear distribution. When we examined cells that expressed the d3G1 and d3NS constructs, we found that these cells also had these large lipid droplets but that the droplets were less numerous.
We used 2 approaches to analyze the apparent differences in lipid content between the d3 constructs. The first approach was based on image analysis by use of MetaMorph software. We have used MetaMorph in the past and have validated its use for the quantitation of ORO content in a high-power field [28] . After statistical analysis of 20 high-power fields per construct, the d3S-expressing cells were found to have almost 2-fold more ORO content than did the d3NS-expressing cells and 40% more ORO content than did the d3G1-expressing cells ( Figure 2B) .
The second method of lipid quantitation was direct measurement of triglyceride content in the stable cells. The results mirrored the differences that were observed in the MetaMorph analysis. The d3S-expressing cells had 2-fold more triglyceride content than did the d3NS-expressing cells and ∼30% more triglyceride content than did the d3G1-expressing cells (Figure 3) .
Markers of ER stress are not elevated in d3-expressing cells. Given that d3 is the "signal peptide" and has been shown to localize to the ER membrane, we sought to evaluate the contribution of ER stress to lipid accumulation caused by d3 [32] [33] [34] . We evaluated 2 markers of ER stress, GRP-78 (BiP) and CHOP (GRP-94), in our stable cell lines that expressed d3 constructs. We incubated 5H cells with 10 mg/mL tunicamycin as a positive control. As shown in Figure 4 , GRP-78 expression was increased in tunicamycin-treated cells but equivalent between the control and all d3-expressing cells. The same was true for CHOP.
d3 does not colocalize with lipid droplets while causing lipid accumulation. Because we established that d3 was sufficient for lipid accumulation, we next sought to determine the intracellular compartment where the lipids were accumulating. Our previous work and that of others has shown that core protein localizes to lipid droplets and that the residues that are responsible for this localization are within d2 [28, 35] . An unresolved issue is how lipid droplet localization and lipid accumulation are related, if at all. Using ADRP as a marker for lipid droplets, we found that d3 did not colocalize with these large droplets, regardless of which d3 construct was used, as illustrated by the lack of fluorescent overlap ( Figure 5 ), but that d3 was able to cause significant lipid accumulation. We compared the d3 construct to a construct in which d2 was retained with d3 (d2-d3), which should restore the ability to localize to lipid droplets. We observed almost complete overlap of GFP and ADRP staining, which indicated colocalization of this d2-d3 construct with lipid droplets. d3 shows partial colocalization with the Golgi apparatus. After observing the initial results of significant lipid accumulation with d3 and the localization away from the lipid droplet, we sought to determine where in the cell d3 may be mediating this effect. We chose to analyze markers for the ER, the Golgi apparatus, and the peroxisome because of their importance in various phases of lipid metabolism. Analysis of stable cells indicated a partial colocalization of d3 with the Golgi apparatus, on the basis of the overlap of fluorescent staining ( Figure 6A ). There was little or no overlap observed with ER or peroxisomal markers. There were no differences in localization between the d3S, d3G1, or d3NS constructs (data not shown). To confirm this finding, we repeated this experiment with the use of Huh7.5 cells that were transiently transfected with the d3S construct. Again we observed partial colocalization of the d3 construct with the Golgi apparatus ( Figure 6B ).
DISCUSSION
In this study, we have shown that HCV core d3 is sufficient for intracellular lipid accumulation. GFP fusion constructs of d3 alone led to large lipid-containing droplets or aggregates, and the amount of ORO staining was highest in the d3S construct and lowest in the d3NS construct. These results were substantiated by the statistically significantly higher triglyceride accumulation that was observed with the d3S construct compared to the d3NS construct. As determined by our ADRP staining, d3 does not colocalize with lipid droplets to mediate this effect but rather exhibits partial colocalization with the Golgi apparatus in both the stable rat-derived liver cells and the human-derived Huh7.5 cells.
These results have several implications. The first is that the previously attributed role of d3 has been expanded. Most studies have focused on the cleavage events that occur between d2 and d3 and between d3 and the E1 glycoprotein [32, 33, 36] . Specific investigations have previously mutated these cleavage sites and stressed the importance of proper cleavage for virus assembly and release [37] [38] [39] . Our previous work, which defined polymorphisms within d3 and subsequently used sitespecific mutagenesis, provided cause for reconsideration [28] . This work provides further evidence that d3 mediates much more than just cleavage events.
The second implication is that the phenomena of lipid droplet binding and lipid accumulation have been further separated. Many of the previous studies have focused on the importance of regions within d2 for lipid droplet binding [25, 35] . In our previous study, we hypothesized that these 2 phenomena may be mediated by 2 distinct regions of the core protein. This study provides specific support of our hypothesis by showing that d3 constructs alone caused significant lipid accumulation in the absence of colocalization to the lipid droplet but that d3 colocalized to lipid droplets when combined with d2. These results are in contrast to the results of other studies that described the importance of residue 164 and phenylalanine, which is a hallmark of genotype 3 constructs, in causing the upreg-ulation of fatty acid synthase [40, 41] . Our previous data made us skeptical of the importance of this result, given that steatosis and nonsteatosis isolates both had the F164 residue yet showed statistically significant differences in the amount of lipid accumulating. We hypothesize that this residue may serve to maintain the lipid content of droplets already formed but that it is not likely to be the primary cause of lipid accumulation.
The third implication is the apparent importance of seemingly subtle sequence differences within d3. The nonsteatosis construct, which was a genotype 3 isolate that differed by only a single amino acid at position 186 (isoleucine instead of valine), still caused lipid to accumulate but at approximately one-half the amount seen with the steatosis construct. The lipid accumulation for the genotype 1 construct was between that of the steatosis construct and that of the nonsteatosis construct, but it was closer to that of the nonsteatosis construct. We interpret these results as support for the selection over time of sequences that maintain the hydrophobic helix formation, which is required for proper cleavage at the proximal and distal ends, and that also allow for enough lipids to accumulate that viral replication is enabled and assembly occurs. Alanine scanning by means of the JFH-1 system through this region of core protein had minimal effect on viral titers, which supports our hypothesis because alanine substitution would preserve the helix structure [42] . Some sequences clearly exceed that minimum requirement, which we hypothesize to lead to the virus-induced steatosis observed in patients with chronic infection. Given the results of previous studies and the role of d3 as the "signal peptide," we were surprised by the lack of colocalization with the ER. However, the partial colocalization of d3 with the Golgi apparatus may provide insights about a possible mechanism. We hypothesize that d3 alters the trafficking of triglycerides and other lipids by means of a hitherto unidentified mechanism and allows them to accumulate. More specific studies on the natural life cycle of d3 after cleavage and specific studies on lipid trafficking will help to address this issue.
Our results should be analyzed in light of certain limitations. First, although we are using GFP fusion constructs, which might raise concern about the context of our results, our d3-expressing cells resemble Huh7.5 cells that express a mutant core protein with an altered cleavage site between d2 and d3 [39] . These cells had increased lipid amounts and had multiple large vacuolar structures that were similar to those seen in our d3-expressing cells. Second, this system lacks the context of other viral proteins and the entire viral life cycle. These results, however, still are consistent with previous results, given the accumulation of free cholesterol with d3 constructs and the genotype differences.
In conclusion, we have demonstrated that HCV core d3 is sufficient for intracellular lipid accumulation and further underlined the importance of subtle sequence changes in the ability of d3 to cause lipid accumulation. These data provide further evidence for an expanded role of d3 in the viral life cycle beyond simple cleavage events and possibly indicate that altered trafficking is the most likely or dominant role. Elucidation of the specific mechanisms of lipid accumulation may serve to uncover a pan-genotype drug target that would serve to disrupt an early step in the viral life cycle.
